For people on dialysis waiting for a kidney transplant, managing a mineral called phosphate could be just as important as passing medical tests. When kidneys fail, they can no longer filter excess phosphate from the blood, leading to buildup that damages bones, blood vessels, and the heart. New research shows that patients who enter transplant surgery with well-controlled phosphate levels have better outcomes, including longer-lasting transplanted kidneys and faster recovery after surgery .

Why Does Phosphate Matter So Much for Transplant Success?

Phosphate is a mineral found in many foods that helps build bones and supports body functions. Healthy kidneys remove excess phosphate, but when kidney function declines, phosphate accumulates even in people on dialysis. This buildup triggers a cascade of problems throughout the body .

High phosphate levels pull calcium out of bones, weakening them and increasing fracture risk. At the same time, phosphate and calcium can deposit in blood vessel walls and heart tissue, causing hardening of the arteries, high blood pressure, and increased risk of heart attack and stroke. High phosphate also stimulates a hormone called FGF-23, which can be toxic to people with kidney disease. Additionally, elevated FGF-23 suppresses Klotho, an important hormone that protects blood vessels from damage. For dialysis patients, heart and blood vessel disease is the leading cause of death, and high phosphate is a major, changeable risk factor for these problems .

Studies show that people who go into transplant surgery with very high phosphate levels have higher chances of delayed kidney function right after surgery and a higher risk of losing the transplanted kidney over time. Lower, well-controlled phosphate levels before transplant are linked with better graft survival and better overall outcomes after surgery .

"Better phosphate control may shorten waiting time on dialysis therapy, support stronger bones and healthier blood vessels, improve the chances that a transplant center will consider a patient ready, and help the transplanted kidney work better and last longer," explained Stephen Z. Fadem, MD, FACP, FASN.

Stephen Z. Fadem, MD, FACP, FASN, Clinical Professor of Medicine at Baylor College of Medicine

What Is "Transplant Readiness" and How Does Phosphate Fit In?

The American Association of Kidney Patients (AAKP) defines "transplant readiness" not just as meeting a clinic's medical checklist, but as a patient's opportunity and ability to pursue kidney transplantation when it aligns with their personal goals and aspirations. Many transplant centers look at phosphate as one sign of how well a patient is managing their health and how ready they are for a transplant, even if a normal phosphate level is not an official requirement .

However, experts emphasize that transplant readiness includes several interconnected elements beyond lab numbers. These factors shape whether a patient can successfully receive and maintain a transplanted kidney:

• Understanding all options: Patients need clear information about all kidney replacement therapies available to them.
• Access to treatments: Removal of barriers to all safe and effective FDA-approved treatments that support an individual's ability to remain healthy enough to receive a transplant.
• Alignment with life goals: The treatment plan must match a patient's personal aspirations and values as they define them.
• Empowerment through education: Patients should receive respect for their autonomy and the knowledge needed to make informed decisions.

How to Manage Phosphate Levels Before Transplant

Managing phosphate is challenging for most dialysis patients, but several approaches can help. Standard tools include dietary changes and medication, though newer options are emerging:

• Dietary modifications: Limiting processed foods and certain high-phosphate foods can reduce phosphate intake, though this requires sustained effort and education.
• Phosphate binder pills: These medications are taken with meals and work by trapping phosphate in the gut so it is not absorbed into the bloodstream.
• Newer intestinal blockers: Medications that block phosphate absorption in the intestine offer additional help, though more research is needed on their long-term effectiveness.
• Parathyroid hormone control: Medicines that control parathyroid hormone levels may support better phosphate management.
• Vitamin K2 supplementation: Emerging evidence suggests vitamin K2 may help protect blood vessels, though additional research is ongoing.

Despite these options, a large share of dialysis patients still have phosphate above target levels. The main barriers include high pill burden, side effects from medications, and the challenge of following strict diet and fluid limits .

The Fairness Question: How Phosphate Levels Affect Transplant Access

While controlling phosphate is medically important, experts raise an important concern about equity. Lab results such as phosphate levels can be affected by access to healthy food, medications, and medical care. Using them in transplant decisions can sometimes worsen existing inequalities if not handled carefully .

To address this, researchers argue that tracking wait-list times, transplant rates, and posttransplant results by phosphate levels and by type of phosphate-lowering treatment could help make decisions more transparent and fairer. This approach would reveal whether certain populations face barriers to accessing the treatments and education needed to achieve good phosphate control .

What This Means for People Waiting for a Kidney Transplant

For someone on dialysis hoping for a transplant, controlling phosphate should be viewed as part of preparing the body for a new kidney, not just "fixing a lab number." The practical benefits are significant. Better phosphate control may shorten waiting time on dialysis, support stronger bones and healthier blood vessels, improve the chances that a transplant center will consider a patient ready, and help the transplanted kidney work better and last longer. Expanding access to effective phosphate-lowering options and tracking their impact on transplant access and outcomes may improve patient outcomes and reduce overall care costs .

Chronic kidney disease affects around 10 to 12 percent of the population, and some may progress to end-stage kidney disease, where the kidneys no longer work well enough on their own. At that point, treatment options are dialysis or a kidney transplant, and a transplant usually offers longer life, better quality of life, and lower overall medical costs than staying on dialysis . For those pursuing this path, phosphate management is an often-overlooked but critical piece of the puzzle.